Cargando…
Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1
Estrogen receptor α (ERα) is the major driver for breast tumor carcinogenesis and progression, while ERα positive breast cancer is the major subtype in breast malignancies, which account for 70% breast cancers in patients. The success of endocrine therapy such as tamoxifen is one of the biggest brea...
Autores principales: | Ding, Jianing, Kuang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173209/ https://www.ncbi.nlm.nih.gov/pubmed/34094957 http://dx.doi.org/10.3389/fonc.2021.664689 |
Ejemplares similares
-
Structural basis for ubiquitylation by HOIL-1
por: Wu, Qilong, et al.
Publicado: (2023) -
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019) -
Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
por: Shi, Liang, et al.
Publicado: (2015) -
The quest for the “HOIL-1” grail of T-cell development
por: Alves, Nuno L., et al.
Publicado: (2021) -
HOXA1 Is an Antagonist of ERα in Breast Cancer
por: Belpaire, Magali, et al.
Publicado: (2021)